Physician profile
Brian Bernhardt
NPI 1255594909
$4,355.43
in general payments reported to CMS, 2019-2025
21 companies · $629 in 2025
The $629 reported for 2025 was more than what 92% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $906 · 2020: $151 · 2021: $169 · 2022: $647 · 2023: $1,176 · 2024: $677 · 2025: $629.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,179 · Travel and Lodging: $303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,178.58 |
| Travel and Lodging | $303.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,749.91 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Nevro Corp. | $724.39 | 2019-2024 | Senza |
| Curonix LLC | $312.29 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertos Medical, INC. | $286.87 | 2022 | |
| Electronic Waveform Lab, INC. | $250.01 | 2019-2021 | |
| Averitas Pharma INC. | $218.52 | 2023-2024 | Qutenza |
| Medtronic, INC. | $188.44 | 2021-2023 | Intellis Adaptivestim |
| Abbott Laboratories | $128.26 | 2022-2025 | Eterna |
| Globus Medical, INC. | $109.38 | 2025 | Senza |
| Saluda Medical Americas, INC. | $74.76 | 2023-2024 | Evoke Scs, Evoke |
| Arbor Pharmaceuticals, INC. | $67.10 | 2019 | |
| Scilex Pharmaceuticals INC. | $48.30 | 2019 | |
| Biodelivery Sciences International, INC. | $39.20 | 2019-2020 | |
| Stimwave Technologies Incorporated | $38.71 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.69 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fisher & Paykel Healthcare INC | $18.55 | 2025 | Fisher & Paykel Healthcare |
| Orthogenrx INC. | $17.53 | 2020 | |
| Pfizer INC. | $17.01 | 2019 | |
| Avanos Medical | $15.68 | 2022 | |
| Mdd US Operations, LLC | $13.37 | 2019 | |
| Spr Therapeutics, INC | $12.46 | 2024 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Bernhardt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.